中美前药制备专利侵权风险判定规则初探

A preliminary study on the judicial rules of patent infringement risk evaluation of prodrug preparation in China and United States

本文在对比中美两国对于前药专利侵权判定司法实践的基础上,分析了中美两国有关专利共同侵权和诱导侵权的判定规则,借鉴美国法院对于专利诱导侵权的审理思路,模拟了药品研发过程中可能出现的与前药制备有关的专利侵权风险案例,为我国创新主体在药品研发过程中如何合理规避、排查与化解药品研发经营中的前药专利侵权风险提供了建议。

This paper compares the judicial decisions in the area of patent infringement involving prodrug preparation process between China and United States. On the basis of the comparison,we analyze and summarize the judicial rules on the joint infringement and induced infringement in both countries. In view of the opinion on the court decisions of the United States,here we propose potential legal solutions or legal guidance to help the pharmaceutical enterprises and researchers to investigate and avoid any possible patent infringement risk in the development or marketing prodrug products.